Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease
Drug Metabolism and Disposition · 2025
DOI: 10.1016/j.dmd.2025.100119 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2025. Verfasst von Xia Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of Gastroenterology, the Sixth Affiliated…. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Leukopenia, Mercaptopurine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Health Commission of the People's Republic of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Thiopurine-induced leucopenia (TIL) affects more than 20% of Asians despite dose optimization via NUDT15 and TPMT genotyping. Elevated levels of DNA-thioguanine nucleotide (DNA-TG) have been implicated in the development of TIL. This study aimed to identify genetic polymorphisms influencing TIL through the DNA-TG metabolic pathway and construct a predictive model in Chinese inflammatory bowel disease patients. A prospective cohort of inflammatory bowel disease patients receiving thiopurines from December 2018 to December 2019 was analyzed. A total of 294 single-nucleotide polymorphisms across 29 genes were screened using the MassARRAY system. Candidate single-nucleotide polymorphisms associated with DNA-TG exposure or TIL (P T), TPMT (rs9465102), MOCOS (rs73430958), and RRM1 (rs1735053), were identified as independent predictors of TIL. The resulting nomogram demonstrated good discriminative performance (area under the curve = 0.72, 95% confidence interval: 0.65-0.78). Individuals stratified into low-, medium-, and high-risk groups based on total point thresholds (25.0 and 196.8), showed significant differences in TIL incidence in both NUDT15 variants and nonvariants (P = 1.8×10-5, P = .045). Our findings indicate that in addition to NUDT15, novel genetic variants in TPMT, MOCOS, and RRM1 are potential predictive markers of TIL. The new nomogram enables more accurate identification of individuals at high risk of TIL, allowing for the proactive adjustment of thiopurine therapy. SIGNIFICANCE STATEMENT: Compared with prior studies limited to NUDT15 and TPMT variants, it was the first pharmacogenomic study to investigate genetic polymorphisms affecting thiopurine-induced leucopenia (TIL) and DNA-thioguanine nucleotide metabolism, constructing a clinically actionable TIL prediction model. We identified novel associations of TPMT, MOCOS, and RRM1 variants with TIL risk, offering key insights for precision dosing in Asian populations. The validated nomogram integrates these biomarkers to stratify patients into distinct risk groups, facilitating tailored thiopurine therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of Gastroenterology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Provinc…
- Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China.
- Department of Gastroenterology, the Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Guangdong Institute of Gastroenterology, Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseas…
- Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, China. Electronic address: huangmin@mail.sysu.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Health Commission of the People's Republic of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zhu, X., Wang, X. D., Xuan, Q. L., Guan, S. X., Guan, Y. P., Gao, X., Chao, K., & Huang, M. (2025). Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease. Drug Metabolism and Disposition. https://doi.org/10.1016/j.dmd.2025.100119
Vancouver
Zhu X, Wang XD, Xuan QL, Guan SX, Guan YP, Gao X, et al. Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease. Drug Metabolism and Disposition. 2025. doi:10.1016/j.dmd.2025.100119
BibTeX
@article{Zhu2025,
author = {Zhu, Xia and Wang, Xue-Ding and Xuan, Qiao-Lan and Guan, Shao-Xing and Guan, Yan-Pin and Gao, Xiang and Chao, Kang and Huang, Min},
title = {Establishment of a novel predictive model for thiopurine-induced leucopenia based on the polymorphisms in the DNA-thioguanine nucleotide metabolite pathway in Chinese patients with inflammatory bowel disease},
journal = {Drug Metabolism and Disposition},
year = {2025},
doi = {10.1016/j.dmd.2025.100119}
}
EUVIMED